Tabula Rasa HealthCare (TRHC) Upgraded at BidaskClub

BidaskClub upgraded shares of Tabula Rasa HealthCare (NASDAQ:TRHC) from a hold rating to a buy rating in a research note released on Tuesday morning.

TRHC has been the topic of a number of other reports. Citigroup lifted their price objective on shares of Tabula Rasa HealthCare to $100.00 and gave the company a buy rating in a report on Thursday, October 11th. Robert W. Baird lifted their price objective on shares of Tabula Rasa HealthCare from $70.00 to $90.00 and gave the company an outperform rating in a report on Wednesday, September 19th. Stifel Nicolaus initiated coverage on shares of Tabula Rasa HealthCare in a report on Tuesday, September 11th. They issued a hold rating and a $95.00 price objective on the stock. Cantor Fitzgerald initiated coverage on shares of Tabula Rasa HealthCare in a report on Thursday, September 6th. They issued an overweight rating and a $99.00 price objective on the stock. Finally, Oppenheimer lifted their price objective on shares of Tabula Rasa HealthCare from $65.00 to $86.00 and gave the company an outperform rating in a report on Thursday, August 23rd. Two equities research analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company’s stock. The company presently has an average rating of Buy and an average target price of $81.60.

TRHC traded down $0.92 during trading on Tuesday, reaching $72.89. The company had a trading volume of 3,524 shares, compared to its average volume of 329,040. The company has a debt-to-equity ratio of 0.11, a quick ratio of 0.33 and a current ratio of 0.36. Tabula Rasa HealthCare has a 12 month low of $27.10 and a 12 month high of $91.16. The firm has a market cap of $1.36 billion, a P/E ratio of -1,823.00, a PEG ratio of 5.08 and a beta of 2.58.

Tabula Rasa HealthCare (NASDAQ:TRHC) last announced its quarterly earnings results on Tuesday, November 6th. The company reported $0.26 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.19 by $0.07. Tabula Rasa HealthCare had a negative net margin of 13.49% and a positive return on equity of 7.53%. The firm had revenue of $54.42 million for the quarter, compared to analyst estimates of $52.87 million. During the same quarter in the previous year, the firm posted $0.08 earnings per share. The business’s revenue was up 66.3% on a year-over-year basis. On average, sell-side analysts anticipate that Tabula Rasa HealthCare will post 0.53 earnings per share for the current fiscal year.

In other news, CEO Calvin H. Knowlton sold 8,000 shares of Tabula Rasa HealthCare stock in a transaction that occurred on Friday, September 7th. The shares were sold at an average price of $85.98, for a total value of $687,840.00. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Insiders sold 48,000 shares of company stock worth $3,722,960 over the last quarter. 14.00% of the stock is owned by corporate insiders.

A number of institutional investors and hedge funds have recently modified their holdings of the stock. Chicago Equity Partners LLC increased its holdings in Tabula Rasa HealthCare by 6.4% during the third quarter. Chicago Equity Partners LLC now owns 15,050 shares of the company’s stock worth $1,222,000 after buying an additional 900 shares during the last quarter. Mckinley Capital Management LLC Delaware increased its holdings in Tabula Rasa HealthCare by 60.5% during the second quarter. Mckinley Capital Management LLC Delaware now owns 2,431 shares of the company’s stock worth $155,000 after buying an additional 916 shares during the last quarter. State of Alaska Department of Revenue increased its holdings in Tabula Rasa HealthCare by 22.4% during the third quarter. State of Alaska Department of Revenue now owns 5,445 shares of the company’s stock worth $442,000 after buying an additional 995 shares during the last quarter. Louisiana State Employees Retirement System increased its holdings in Tabula Rasa HealthCare by 21.3% during the third quarter. Louisiana State Employees Retirement System now owns 7,400 shares of the company’s stock worth $601,000 after buying an additional 1,300 shares during the last quarter. Finally, D.A. Davidson & CO. increased its holdings in Tabula Rasa HealthCare by 12.8% during the second quarter. D.A. Davidson & CO. now owns 12,603 shares of the company’s stock worth $804,000 after buying an additional 1,427 shares during the last quarter. Institutional investors and hedge funds own 75.88% of the company’s stock.

About Tabula Rasa HealthCare

Tabula Rasa HealthCare, Inc operates as a healthcare technology company in the United States. It offers medication risk management, pharmacy cost management, and medicare risk adjustment services. The company offers its technology-enabled products and services to prescribers, pharmacists, and healthcare organizations for medication risk management and risk adjustment.

Recommended Story: How can you know how many shares are floating?

Analyst Recommendations for Tabula Rasa HealthCare (NASDAQ:TRHC)

Receive News & Ratings for Tabula Rasa HealthCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tabula Rasa HealthCare and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply